These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35397522)

  • 61. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
    Mortensen MB; Fuster V; Muntendam P; Mehran R; Baber U; Sartori S; Falk E
    J Am Coll Cardiol; 2016 Aug; 68(9):881-91. PubMed ID: 27561760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Temporal trends in atherosclerotic cardiovascular disease risk among U.S. adults. Analysis of the National Health and Nutrition Examination Survey, 1999-2018.
    Chobufo MD; Singla A; Rahman EU; Michos ED; Whelton PK; Balla S
    Eur J Prev Cardiol; 2022 Dec; 29(18):2289-2300. PubMed ID: 35919951
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 10-year risk for atherosclerotic cardiovascular disease and coronary heart disease among Korean adults: findings from the Korean National Health and Nutrition Examination Survey 2009-2010.
    Lee K
    Int J Cardiol; 2014 Sep; 176(2):418-22. PubMed ID: 25129293
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
    Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM
    Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
    Wong ND; Budoff MJ; Ferdinand K; Graham IM; Michos ED; Reddy T; Shapiro MD; Toth PP
    Am J Prev Cardiol; 2022 Jun; 10():100335. PubMed ID: 35342890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Vasan RS; Enserro DM; Xanthakis V; Beiser AS; Seshadri S
    Circulation; 2022 Apr; 145(17):1324-1338. PubMed ID: 35430874
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score.
    Mee TC; Aepfelbacher J; Krakora R; Chairez C; Kvaratskhelia N; Smith B; Sandfort V; Hadigan C; Morse C; Hammoud DA
    Antivir Ther; 2018; 23(8):695-698. PubMed ID: 30088806
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Gooding HC; Ning H; Gillman MW; Shay C; Allen N; Goff DC; Lloyd-Jones D; Chiuve S
    JAMA Intern Med; 2017 Sep; 177(9):1354-1360. PubMed ID: 28715555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.
    Whelton SP; McEvoy JW; Shaw L; Psaty BM; Lima JAC; Budoff M; Nasir K; Szklo M; Blumenthal RS; Blaha MJ
    JAMA Cardiol; 2020 Sep; 5(9):1011-1018. PubMed ID: 32936272
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol.
    Wong ND; Amsterdam EA; Ballantyne C; Khera A; Nasir K; Toth PP;
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):1-9. PubMed ID: 31286451
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan.
    Li YH; Chen JW; Lin TH; Wang YC; Wu CC; Yeh HI; Huang CC; Chang KC; Wu CK; Chen PW; Huang CW; Chen ZC; Chang WT; Huang WC; Wang CY; Lee MY; Chao AC; Fu WR; Tsai LK; Tang SC; Chan HL; Yang YC; Wu YW; Hwang JJ; Lin JL
    J Formos Med Assoc; 2020 Mar; 119(3):674-684. PubMed ID: 31113748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association between Social Isolation and Loneliness with Estimated Atherosclerotic Cardiovascular Disease Risk in a UK Biobank Population-Based Study.
    Vallée A
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.
    Al-Shamsi S
    BMJ Open; 2022 Dec; 12(12):e064502. PubMed ID: 36581433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The relationship between the atherosclerotic cardiovascular disease risk score used in the prediction of cardiovascular disease risk and endocan.
    Cakirca M; Dae SA; Zorlu M; Kiskac M; Tunc M; Karatoprak C
    Niger J Clin Pract; 2019 May; 22(5):713-717. PubMed ID: 31089028
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women.
    Freaney PM; Khan SS; Lloyd-Jones DM; Stone NJ
    Curr Atheroscler Rep; 2020 Jul; 22(9):46. PubMed ID: 32671475
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modifiable Risk Factors Versus Age on Developing High Predicted Cardiovascular Disease Risk in Blacks.
    Bress AP; Colantonio LD; Booth JN; Spruill TM; Ravenell J; Butler M; Shallcross AJ; Seals SR; Reynolds K; Ogedegbe G; Shimbo D; Muntner P
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28179220
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.
    Honda T; Chen S; Hata J; Yoshida D; Hirakawa Y; Furuta Y; Shibata M; Sakata S; Kitazono T; Ninomiya T
    J Atheroscler Thromb; 2022 Mar; 29(3):345-361. PubMed ID: 33487620
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The 2013 ACC/AHA risk score and subclinical cardiac remodeling and dysfunction: Complementary in cardiovascular disease prediction.
    Cauwenberghs N; Hedman K; Kobayashi Y; Vanassche T; Haddad F; Kuznetsova T
    Int J Cardiol; 2019 Dec; 297():67-74. PubMed ID: 31623873
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.